Concord Biotech Limited IPO
IPO Timeline
| Start Date | 4 August 2023 to 8 August 2023 |
| Allotment Date | 11 August 2023 |
| Refund Initiation | 14 August 2023 |
| Demat Transfer | 17 August 2023 |
| Listing Date | 18 August 2023 |
IPO Details
| Issue Size | ₹1,551.00 Cr |
| Offer for Sale | ₹1,551.00 Cr |
| Minimum Lot Size | 20 (₹14,820) |
| Price Range | ₹705 to ₹741 per share |
| Retail Quota | Not less than 35% of the Net Issue |
| QIB Quota | Not more than 50% of the Net Issue |
| NII Quota | Not less than 15% of the Net Issue |
| No. of Shares Offered | 104,616,204 |
| Promoter Holding Pre IPO | Update soon |
| (D)RHP | Update Soon… |
| Listing on | NSE and BSE |
Concord Biotech Limited IPO Lot Size
| Application Type | Lot Size | Shares | Ammount |
|---|---|---|---|
| Retail Minimum | 1 | 20 | ₹14,820 |
| Retail Maximum | 13 | 260 | ₹192,660 |
| S-HNI (Min) | 14 | 280 | ₹207,480 |
| S-HNI (Max) | 67 | 1,340 | ₹992,940 |
| B-HNI (Min) | 68 | 1,360 | ₹1,007,760 |
Financial Conditions of Concord Biotech Limited
| Year | Total Income (in Crore) | Total Expense (in Crore) | PAT (in Crore) |
|---|---|---|---|
| 2023 | ₹888 | ₹568 | ₹240 |
| 2022 | ₹736 | ₹495 | ₹175 |
| 2021 | ₹631 | ₹318 | ₹235 |
